JPY 1551.0
(-1.27%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Cash Flow | 660.97 Million | -37.57 Million | -39.92 Million | 36.36 Million | 84.38 Million |
Net Income | 330.47 Million | 28.81 Million | -155.94 Million | -362.55 Million | 65.35 Million |
Depreciation & Amortization | 41.29 Million | 71.82 Million | 71.77 Million | 63.74 Million | 114.31 Million |
Deferred income taxes | - | - | - | - | - |
Stock-based compensation | 6.5 Million | 23.23 Million | 32.92 Million | 35.41 Million | - |
Change in working capital | 229.68 Million | -193.01 Million | 663 Thousand | 349.21 Million | -168.02 Million |
Other non-cash items | 74.31 Million | 36.94 Million | -37.06 Million | -80.34 Million | 511.83 Million |
Investing Cash Flow | -500.02 Million | 465.91 Million | -77.34 Million | 68.62 Million | -958.34 Million |
Investments in PPE | -27.28 Million | -35.72 Million | -37.48 Million | -30.82 Million | -41.35 Million |
Acquisitions | - | - | - | - | -11.67 Million |
Investment purchases | -1.07 Billion | -600 Million | -640.74 Million | -600 Million | -1.2 Billion |
Sales/Maturities of investments | 600 Million | 1.1 Billion | 600 Million | 700 Million | 300 Million |
Other Investing Activities | -474 Million | 1.63 Million | 877 Thousand | -551 Thousand | -1.61 Million |
Financing Cash Flow | -291 Thousand | -108 Thousand | -90 Thousand | -1.5 Million | 1.42 Billion |
Debt repayment | - | - | - | - | - |
Dividends payments | - | - | - | - | - |
Common Stock Repurchased | -291 Thousand | -108 Thousand | -90 Thousand | -1.5 Million | - |
Common Stock Issuance | - | - | - | -1.46 Million | 1.42 Billion |
Other Financing Activities | - | - | - | -1 Million | - |
Accounts receivables | 587 Million | -444 Million | -231 Million | 455 Million | -45.94 Million |
Accounts payables | -356.99 Million | 292.89 Million | 128 Million | -6.2 Million | -154.7 Million |
Inventory | -16.8 Million | -26.57 Million | 12.78 Million | -34.77 Million | -9.81 Million |
Other working capital | 66 Million | 54 Million | 42 Million | -79 Million | 42.44 Million |
Cash at beginning of period | 2.43 Billion | 2 Billion | 2.11 Billion | 2 Billion | 1.44 Billion |
Cash at end of period | 2.6 Billion | 2.43 Billion | 2 Billion | 2.11 Billion | 1.99 Billion |
Capital Expenditure | -27.28 Million | -35.72 Million | -37.48 Million | -30.82 Million | -41.35 Million |
Effect of forex changes on cash | 7.09 Million | 5.22 Million | 7.54 Million | 2.2 Million | - |
Net cash flow / Change in cash | 167.75 Million | 433.45 Million | -109.81 Million | 105.68 Million | 552.91 Million |
Free Cash Flow | 633.69 Million | -73.3 Million | -77.4 Million | 5.53 Million | 43.03 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 59 Million | 110 Million | 330.47 Million | 100 Million | 95 Million | 26 Million |
Depreciation & Amortization | - | - | 41.29 Million | - | - | - |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | 6.5 Million | - | - | - |
Change in working capital | - | - | 229.68 Million | - | - | - |
Other non-cash items | -59 Million | -110 Million | 74.31 Million | -100 Million | -95 Million | -26 Million |
Investing Cash Flow | - | - | -500.02 Million | - | - | - |
Investments in PPE | - | - | -27.28 Million | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | -1.07 Billion | - | - | - |
Sales/Maturities of investments | - | - | 600 Million | - | - | - |
Other Investing Activities | - | - | -474 Million | - | - | - |
Financing Cash Flow | - | - | -291 Thousand | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | -291 Thousand | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | 587 Million | - | - | - |
Accounts payables | - | - | -356.99 Million | - | - | - |
Inventory | - | - | -16.8 Million | - | - | - |
Other working capital | - | - | 66 Million | - | - | - |
Cash at beginning of period | - | - | 2.43 Billion | - | - | - |
Cash at end of period | - | - | 2.6 Billion | - | - | - |
Capital Expenditure | - | - | -27.28 Million | - | - | - |
Effect of forex changes on cash | - | - | 7.09 Million | - | - | - |
Net cash flow / Change in cash | - | - | 167.75 Million | - | - | - |
Free Cash Flow | - | - | 633.69 Million | - | - | - |
688318
HGH
ILM1
AMPG
IEM
300702